Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2026-2030

Market Size (2024)

USD 22.36 Billion

CAGR (2025-2030)

7.43%

Fastest Growing Segment

Software

Largest Market

     North America

Market Size (2030)

USD 33.99 Billion

Market Overview

Global Digital Health For Cardiovascular Market was valued at USD 22.36 Billion in 2024 and is expected to reach USD 33.99 Billion by 2030 with a CAGR of 7.43% during the forecast period. The global digital health market for cardiovascular care is experiencing significant growth, driven by the increasing prevalence of cardiovascular diseases (CVDs), advancements in healthcare technology, and the rising demand for personalized healthcare solutions. Digital health technologies, including remote monitoring devices, telemedicine platforms, mobile health apps, and artificial intelligence (AI)-driven diagnostic tools, are transforming the way cardiovascular diseases are managed and treated. These innovations are enabling healthcare providers to offer more efficient, accurate, and patient-centered care.

One of the primary drivers of this market is the global rise in cardiovascular diseases, which remains a leading cause of mortality. Factors such as aging populations, sedentary lifestyles, and unhealthy diets are contributing to the increasing number of CVD cases, creating a demand for more advanced healthcare solutions. Digital health technologies allow for continuous monitoring of patients' vital signs, such as heart rate and blood pressure, offering early detection of abnormalities and enabling timely interventions.

However, challenges such as data privacy concerns, regulatory hurdles, and the need for seamless integration with existing healthcare infrastructure may impede the full adoption of digital health technologies. Ensuring patient data security and compliance with healthcare regulations is crucial for building trust in these technologies. Moreover, healthcare systems must invest in training and support for healthcare professionals to effectively utilize digital tools in cardiovascular care.

Key Market Drivers

Growth in Healthcare Industry

The growth of the healthcare industry has been a significant driver of the global digital health market, particularly in the cardiovascular segment. Heart disease is the leading cause of death among men, women, and individuals across most racial and ethnic groups. Every 33 seconds, one person succumbs to cardiovascular disease. In 2022, heart disease claimed 702,880 lives, representing 1 in every 5 deaths. Each year, approximately 805,000 individuals in the United States experience a heart attack, with 605,000 being first-time incidents and 200,000 occurring in individuals who have previously suffered a heart attack. With the increasing prevalence of cardiovascular diseases worldwide, healthcare providers are seeking more efficient ways to manage and monitor patient health. This demand has led to the rapid adoption of digital health technologies, including telemedicine, wearable devices, and remote monitoring systems, designed to enhance cardiovascular care.

One key factor contributing to this growth is the rising burden of cardiovascular diseases, driven by factors such as aging populations, unhealthy lifestyles, and increased incidences of hypertension and diabetes. According to the IDF Diabetes Atlas (2021), 10.5% of adults aged 20 to 79 are currently affected by diabetes, with nearly half of them unaware of their condition. By 2045, the IDF forecasts that one in eight adults, approximately 783 million people, will be living with diabetes, representing a 46% increase. As a result, healthcare systems are increasingly turning to digital health solutions to improve patient outcomes and reduce the strain on healthcare resources. These technologies enable real-time monitoring of patients, allowing for early detection of potential issues and timely interventions, which is particularly crucial in managing chronic conditions like heart disease.

Surge in Technological Advancements

The rapid surge in technological advancements is emerging as a significant driver of growth in the global digital health market for cardiovascular care. Innovations in digital health technologies, such as wearable devices, artificial intelligence (AI), and mobile health applications, are transforming how cardiovascular conditions are monitored, diagnosed, and treated. These technologies offer healthcare providers and patients new avenues to manage cardiovascular diseases more efficiently, leading to improved health outcomes and cost-effectiveness.

AI applications extend to detecting heart disease, accelerating stroke treatment, and improving diagnostic radiology capabilities. A Mayo Clinic study, for instance, employed AI techniques in a new screening tool for individuals with a specific heart condition known as left ventricular dysfunction, which often presents without noticeable symptoms. The AI-powered tool successfully identified individuals at risk 93% of the time. To provide context, mammograms have an accuracy rate of 85%. Furthermore, AI developed at Mayo Clinic is also integrated into the Apple Watch to detect low ventricular ejection fraction, indicating a weak heart pump.

Wearable devices, such as smartwatches and fitness trackers equipped with heart rate monitors, electrocardiograms (ECG), and blood pressure sensors, have become essential tools in the early detection of cardiovascular risks. These devices provide real-time monitoring, enabling individuals to track their heart health continuously and seek medical attention promptly if abnormalities are detected. The integration of AI algorithms in wearables further enhances the accuracy of data analysis, providing healthcare professionals with valuable insights into patient conditions. This technological advancement enables early intervention, reducing the risk of severe cardiovascular events such as heart attacks or strokes.


Digital Health For Cardiovascular Market


Download Free Sample Report

Key Market Challenges

Data Privacy and Security Concerns

Data privacy and security concerns present a significant challenge in the global digital health market for cardiovascular care. As healthcare providers increasingly rely on digital health technologies, such as remote monitoring devices, mobile health apps, and AI-driven platforms, vast amounts of sensitive patient data are being generated, transmitted, and stored. Ensuring the protection of this data is critical to maintaining patient trust and meeting stringent regulatory requirements, but it also poses complex challenges.

The nature of cardiovascular care, which often involves continuous monitoring and real-time data transmission, increases the potential risk for data breaches and unauthorized access. Wearable devices and telemedicine platforms frequently collect personal health information, including heart rate, blood pressure, and electrocardiogram (ECG) readings, which, if compromised, could lead to severe consequences. Cyberattacks targeting healthcare systems are on the rise, and a single breach could result in the exposure of confidential patient data, leading to legal, financial, and reputational damage for healthcare organizations.

Key Market Trends

Integration of Digital Health Platforms

The integration of digital health platforms has emerged as a prominent trend in the global digital health market, particularly within the cardiovascular sector. For instance, CANet provides cutting-edge digital health solutions for managing complex cardiovascular conditions. The organization has developed VIRTUES, a comprehensive, integrated approach designed to ensure equitable care for all patients, irrespective of geographical, cultural, or systemic challenges. This transformative initiative aims to deliver the highest standard of cardiovascular care to everyone. As healthcare providers seek to improve patient outcomes and streamline care, there is a growing emphasis on consolidating various digital tools and technologies into unified platforms that offer comprehensive, real-time cardiovascular health management.

One of the primary drivers of this trend is the need for seamless data sharing and communication across healthcare systems. Digital health platforms that integrate electronic health records (EHRs), wearable devices, telemedicine services, and remote monitoring technologies enable healthcare professionals to access a holistic view of a patient’s cardiovascular health. This integration facilitates more accurate diagnostics, personalized treatment plans, and continuous monitoring, reducing the likelihood of adverse events and improving overall care coordination.

Segmental Insights

Component Insights

Based on Component, Software have emerged as the fastest growing segment in the Global Digital Health For Cardiovascular Market in 2024. One key factor driving the growth of software in this sector is the rise of artificial intelligence (AI) and machine learning (ML) algorithms embedded in cardiovascular health software. These tools are capable of processing vast amounts of medical data, including patient records, imaging results, and real-time monitoring data from wearable devices. By analyzing these data streams, AI-driven software can assist healthcare providers in making more accurate diagnoses, identifying trends, and recommending personalized treatment plans. This not only improves the quality of care but also enables quicker decision-making, which is critical in the management of time-sensitive cardiovascular conditions.

End User Insights

Based on End User, Patients have emerged as the fastest growing segment in the Global Digital Health For Cardiovascular Market during the forecast period. The global trend towards remote monitoring and telemedicine has accelerated, particularly for patients with chronic cardiovascular conditions. Devices that allow for continuous monitoring of heart rate, blood pressure, and other key health metrics are becoming increasingly popular. As patients gain more access to telemedicine services, they are more likely to utilize digital health technologies to consult with healthcare professionals and manage their conditions without needing to visit a clinic. This convenience has contributed significantly to the growth of the patient segment in digital cardiovascular health.


Digital Health For Cardiovascular Market


Download Free Sample Report

Regional Insights

Based on Region, North America have emerged as the dominating region in the Global Digital Health For Cardiovascular Market in 2024. North America, particularly the United States, is home to some of the world’s leading tech companies and healthcare innovators. The region's robust investment in research and development has led to the creation of advanced digital health solutions, such as wearable devices, AI-driven health tools, and telemedicine platforms. The continuous influx of capital into health tech startups and established companies further accelerates the development of innovative solutions tailored for cardiovascular care.

Recent Development

  • In 2024, Lupin Digital Health, India’s pioneering evidence-based cardiology Digital Therapeutics (DTx) platform, in collaboration with the American College of Cardiology (ACC), a global leader in cardiology, introduced the world’s first-ever Digital Therapeutics Certificate for Cardiologists. This milestone was revealed during the Platinum Jubilee celebration of the Cardiology Society of India (CSI) in Kolkata. Developed by Lupin Digital Health, Lyfe is India’s first clinically proven remote cardiac rehabilitation program. Designed to address the underutilization of cardiac rehabilitation, Lyfe is currently trusted by over 450 cardiologists and benefits patients in more than 250 towns and cities across India. The program has proven its effectiveness in enhancing heart health and improving the quality of life for cardiovascular patients.
  • In December 2024, Longenesis, a Latvian start-up backed by EIT Health, announced the signing of a Memorandum of Understanding (MoU) with Daugavpils Regional Hospital (DRH) and the global pharmaceutical company Novartis Baltics to launch a pilot project in Latvia aimed at the treatment and prevention of cardiovascular diseases. The initiative will focus on establishing a dynamic digital registry for heart failure and dyslipidemia patients, facilitating improved identification of high-risk groups and enabling timely interventions. Patient enrollment is scheduled to commence at Daugavpils Regional Hospital in early 2025. Longenesis, a leading digital health start-up in the Baltics, is committed to accelerating the delivery of therapies by facilitating the cross-border reuse of health data.
  • In July 2024, WELL Health introduced its new AI-powered physician co-pilot designed to assist cardiologists in more accurately identifying patients at high risk for cardiovascular disease (CVD). WELL has formed an exclusive partnership with HEALWELL AI, a leading provider of AI-driven disease diagnosis solutions, to enhance its WELL AI Decision Support (WAIDS) product suite. The co-pilot will be integrated into WELL Diagnostic Centres, the largest cardiology and medical diagnostic group in Canada, offering support to cardiologists across over 40 locations in Ontario.
  • In March 2025, Apollo Hospitals and Solventum formed a strategic partnership focused on cardiovascular risk prediction. This collaboration will combine Solventum’s patient classification and quality methodologies with Apollo’s AI-driven technology to enhance cardiovascular care. The partnership seeks to assess the impact of their integrated solution on improving population health outcomes and optimizing hospital resource management. Key metrics under evaluation include mortality rates, hospital stay durations, complications, and readmission rates.

Key Market Players

  • Epic Systems Corporation
  • Orange Business
  • Apple, Inc.
  • Siemens Healthineers AG
  • NXGN Management, LLC.
  • GE HealthCare Technologies Inc.
  • CardiAI
  • Ultromics Limited
  • Koninklijke Philips N.V.
  • UltraSight Inc.

By Component

By End User

By Region

  • Software
  • Hardware
  • Services
  • Patients
  • Providers
  • Payers
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Report Scope

In this report, the Global Digital Health For Cardiovascular Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Digital Health For Cardiovascular Market, By Component:

o   Software

o   Hardware

o   Services

  • Digital Health For Cardiovascular Market, By End User:

o   Patients

o   Providers

o   Payers

o   Others

  • Digital Health For Cardiovascular Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Health For Cardiovascular Market.

Available Customizations:

Global Digital Health For Cardiovascular Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Digital Health For Cardiovascular Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

Table of content

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Digital Health For Cardiovascular Market

5. Global Digital Health For Cardiovascular Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Component (Software, Hardware, Services)

5.2.2. By End User (Patients, Providers, Payers, Others)

5.2.3. By Region

5.2.4. By Company (2024) 

5.3. Market Map

6. North America Digital Health For Cardiovascular Market Outlook

6.1. Market Size & Forecast  

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Component

6.2.2. By End User

6.2.3. By Country

6.3. North America: Country Analysis

6.3.1. United States Digital Health For Cardiovascular Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Component

6.3.1.2.2. By End User

6.3.2. Mexico Digital Health For Cardiovascular Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Component

6.3.2.2.2. By End User

6.3.3. Canada Digital Health For Cardiovascular Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Component

6.3.3.2.2. By End User

7. Europe Digital Health For Cardiovascular Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Component

7.2.2. By End User

7.2.3. By Country

7.3. Europe: Country Analysis

7.3.1. France Digital Health For Cardiovascular Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Component

7.3.1.2.2. By End User

7.3.2. Germany Digital Health For Cardiovascular Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Component

7.3.2.2.2. By End User

7.3.3. United Kingdom Digital Health For Cardiovascular Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Component

7.3.3.2.2. By End User

7.3.4. Italy Digital Health For Cardiovascular Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Component

7.3.4.2.2. By End User

7.3.5. Spain Digital Health For Cardiovascular Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Component

7.3.5.2.2. By End User

8. Asia Pacific Digital Health For Cardiovascular Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Component

8.2.2. By End User

8.2.3. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Digital Health For Cardiovascular Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Component

8.3.1.2.2. By End User

8.3.2. India Digital Health For Cardiovascular Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Component

8.3.2.2.2. By End User

8.3.3. South Korea Digital Health For Cardiovascular Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Component

8.3.3.2.2. By End User

8.3.4. Japan Digital Health For Cardiovascular Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Component

8.3.4.2.2. By End User

8.3.5. Australia Digital Health For Cardiovascular Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Component

8.3.5.2.2. By End User

9. South America Digital Health For Cardiovascular Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Component

9.2.2. By End User

9.2.3. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Digital Health For Cardiovascular Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Component

9.3.1.2.2. By End User

9.3.2. Argentina Digital Health For Cardiovascular Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Component

9.3.2.2.2. By End User

9.3.3. Colombia Digital Health For Cardiovascular Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Component

9.3.3.2.2. By End User

10. Middle East and Africa Digital Health For Cardiovascular Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Component

10.2.2. By End User

10.2.3. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Digital Health For Cardiovascular Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Component

10.3.1.2.2. By End User

10.3.2. Saudi Arabia Digital Health For Cardiovascular Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Component

10.3.2.2.2. By End User

10.3.3. UAE Digital Health For Cardiovascular Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Component

10.3.3.2.2. By End User

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Digital Health For Cardiovascular Market: SWOT Analysis

14. Porters Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Epic Systems Corporation

15.1.1. Business Overview

15.1.2. Company Snapshot

15.1.3. Products & Services

15.1.4. Financials (As Reported)

15.1.5. Recent Developments

15.1.6. Key Personnel Details

15.1.7. SWOT Analysis

15.2. Orange Business

15.3. Apple, Inc.

15.4. Siemens Healthineers AG

15.5. NXGN Management, LLC.

15.6. GE HealthCare Technologies Inc.

15.7. CardiAI

15.8. Ultromics Limited

15.9. Koninklijke Philips N.V.

15.10. UltraSight Inc.

16. Strategic Recommendations

17. About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the Global Digital Health For Cardiovascular Market was estimated to be USD 22.36 Billion in 2024.

The software segment demonstrated significant growth in 2024. This is due to its role in improving diagnostic accuracy, enhancing remote care, fostering patient engagement, and enabling data-driven decision-making.

North America dominated the market with a revenue share in 2024. This is driven by its technological advancements, strong healthcare infrastructure, government support, high consumer adoption, and the increasing prevalence of cardiovascular diseases.

Growth in healthcare industry and surge in technological advancements are the major drivers for the Global Digital Health For Cardiovascular Market.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.